APO-FLUTICASONE HFA
APO-FLUTICASONE HFA
Approved
DIN Number
02526557
Drug Class
Human
Market Date
Nov 22, 2022
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02526557
AIG Number0124685004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationOral
,
Inhalation
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE PROPIONATEActive
Strength: 125 MCG / ACT
Monograph: FLUTICASONE PROPIONATE